Loss of p53 Ser18 and Atm results in embryonic lethality without cooperation in tumorigenesis
| dc.contributor.author | Armata, Heather L. | |
| dc.contributor.author | Shroff, Punita | |
| dc.contributor.author | Garlick, David S. | |
| dc.contributor.author | Penta, Krista L. | |
| dc.contributor.author | Tapper, Andrew R. | |
| dc.contributor.author | Sluss, Hayla Karen | |
| dc.date | 2022-08-11T08:09:40.000 | |
| dc.date.accessioned | 2022-08-23T16:39:50Z | |
| dc.date.available | 2022-08-23T16:39:50Z | |
| dc.date.issued | 2011-09-27 | |
| dc.date.submitted | 2012-09-06 | |
| dc.identifier.citation | <p>Armata HL, Shroff P, Garlick DE, Penta K, Tapper AR, et al. (2011) Loss of <em>p53 Ser18</em> and <em>Atm</em> Results in Embryonic Lethality without Cooperation in Tumorigenesis. PLoS ONE 6(9): e24813. doi:10.1371/journal.pone.0024813. <a href="http://dx.doi.org/10.1371/journal.pone.0024813" target="_blank">Link to article on publisher's site</a></p> | |
| dc.identifier.issn | 1932-6203 (Linking) | |
| dc.identifier.doi | 10.1371/journal.pone.0024813 | |
| dc.identifier.pmid | 21980358 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/39559 | |
| dc.description.abstract | Phosphorylation at murine Serine 18 (human Serine 15) is a critical regulatory process for the tumor suppressor function of p53. p53Ser18 residue is a substrate for ataxia-telangiectasia mutated (ATM) and ATM-related (ATR) protein kinases. Studies of mice with a germ-line mutation that replaces Ser18 with Ala (p53(S18A) mice) have demonstrated that loss of phosphorylation of p53Ser18 leads to the development of tumors, including lymphomas, fibrosarcomas, leukemia and leiomyosarcomas. The predominant lymphoma is B-cell lymphoma, which is in contrast to the lymphomas observed in Atm(-/-) animals. This observation and the fact that multiple kinases phosphorylate p53Ser18 suggest Atm-independent tumor suppressive functions of p53Ser18. Therefore, in order to examine p53Ser18 function in relationship to ATM, we analyzed the lifespan and tumorigenesis of mice with combined mutations in p53Ser18 and Atm. Surprisingly, we observed no cooperation in survival and tumorigenesis in compound p53(S18A) and Atm(-/-) animals. However, we observed embryonic lethality in the compound mutant animals. In addition, the homozygous p53Ser18 mutant allele impacted the weight of Atm(-/-) animals. These studies examine the genetic interaction of p53Ser18 and Atm in vivo. Furthermore, these studies demonstrate a role of p53Ser18 in regulating embryonic survival and motor coordination. | |
| dc.language.iso | en_US | |
| dc.relation | <p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=21980358&dopt=Abstract">Link to Article in PubMed</a></p> | |
| dc.rights | <p>Copyright: © 2011 Armata et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p> | |
| dc.subject | Animals | |
| dc.subject | Cell Cycle Proteins | |
| dc.subject | Cell Proliferation | |
| dc.subject | DNA-Binding Proteins | |
| dc.subject | Female | |
| dc.subject | Fibroblasts | |
| dc.subject | *Gene Expression Regulation, Neoplastic | |
| dc.subject | Germ-Line Mutation | |
| dc.subject | Humans | |
| dc.subject | Male | |
| dc.subject | Mice | |
| dc.subject | Mice, Transgenic | |
| dc.subject | Models, Genetic | |
| dc.subject | Mutation | |
| dc.subject | Phosphorylation | |
| dc.subject | Protein-Serine-Threonine Kinases | |
| dc.subject | Tumor Suppressor Protein p53 | |
| dc.subject | Tumor Suppressor Proteins | |
| dc.subject | Cancer Biology | |
| dc.subject | Cell and Developmental Biology | |
| dc.subject | Life Sciences | |
| dc.subject | Medicine and Health Sciences | |
| dc.title | Loss of p53 Ser18 and Atm results in embryonic lethality without cooperation in tumorigenesis | |
| dc.type | Journal Article | |
| dc.source.journaltitle | PloS one | |
| dc.source.volume | 6 | |
| dc.source.issue | 9 | |
| dc.identifier.legacyfulltext | https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=3354&context=oapubs&unstamped=1 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/oapubs/2354 | |
| dc.identifier.contextkey | 3299955 | |
| refterms.dateFOA | 2022-08-23T16:39:51Z | |
| html.description.abstract | <p>Phosphorylation at murine Serine 18 (human Serine 15) is a critical regulatory process for the tumor suppressor function of p53. p53Ser18 residue is a substrate for ataxia-telangiectasia mutated (ATM) and ATM-related (ATR) protein kinases. Studies of mice with a germ-line mutation that replaces Ser18 with Ala (p53(S18A) mice) have demonstrated that loss of phosphorylation of p53Ser18 leads to the development of tumors, including lymphomas, fibrosarcomas, leukemia and leiomyosarcomas. The predominant lymphoma is B-cell lymphoma, which is in contrast to the lymphomas observed in Atm(-/-) animals. This observation and the fact that multiple kinases phosphorylate p53Ser18 suggest Atm-independent tumor suppressive functions of p53Ser18. Therefore, in order to examine p53Ser18 function in relationship to ATM, we analyzed the lifespan and tumorigenesis of mice with combined mutations in p53Ser18 and Atm. Surprisingly, we observed no cooperation in survival and tumorigenesis in compound p53(S18A) and Atm(-/-) animals. However, we observed embryonic lethality in the compound mutant animals. In addition, the homozygous p53Ser18 mutant allele impacted the weight of Atm(-/-) animals. These studies examine the genetic interaction of p53Ser18 and Atm in vivo. Furthermore, these studies demonstrate a role of p53Ser18 in regulating embryonic survival and motor coordination.</p> | |
| dc.identifier.submissionpath | oapubs/2354 | |
| dc.contributor.department | Tapper Lab | |
| dc.contributor.department | Department of Psychiatry | |
| dc.contributor.department | Department of Cancer Biology | |
| dc.contributor.department | Department of Medicine, Division of Endocronology and Metabolism | |
| dc.source.pages | e24813 |
Files in this item
This item appears in the following Collection(s)
Related items
Showing items related by title, author, creator and subject.
-
Dynamic Regulation at the Neuronal Plasma Membrane: Novel Endocytic Mechanisms Control Anesthetic-Activated Potassium Channels and Amphetamine-Sensitive Dopamine Transporters: A DissertationEndocytic trafficking dynamically regulates neuronal plasma membrane protein presentation and activity, and plays a central role in excitability and plasticity. Over the course of my dissertation research I investigated endocytic mechanisms regulating two neuronal membrane proteins: the anesthetic-activated potassium leak channel, KCNK3, as well as the psychostimulant-sensitive dopamine transporter (DAT). My results indicate that KCNK3 internalizes in response to Protein Kinase C (PKC) activation, using a novel pathway that requires the phosphoserine binding protein, 14-3-3β, and demonstrates for the first time regulated KCNK3 channel trafficking in neurons. Additionally, PKC-mediated KCNK3 trafficking requires a non-canonical endocytic motif, which is shared exclusively between KCNK3 and sodium-dependent neurotransmitter transporters, such as DAT. DAT trafficking studies in intact ex vivo adult striatal slices indicate that DAT endocytic trafficking has both dynamin-dependent and –independent components. Moreover, DAT segregates into two populations at the neuronal plasma membrane: trafficking-competent and -incompetent. Taken together, these results demonstrate that novel, non-classical endocytic mechanisms dynamically control the plasma membrane presentation of these two important neuronal proteins.
-
Selective interaction of JNK protein kinase isoforms with transcription factorsThe JNK protein kinase is a member of the MAP kinase group that is activated in response to dual phosphorylation on threonine and tyrosine. Ten JNK isoforms were identified in human brain by molecular cloning. These protein kinases correspond to alternatively spliced isoforms derived from the JNK1, JNK2 and JNK3 genes. The protein kinase activity of these JNK isoforms was measured using the transcription factors ATF2, Elk-1 and members of the Jun family as substrates. Treatment of cells with interleukin-1 (IL-1) caused activation of the JNK isoforms. This activation was blocked by expression of the MAP kinase phosphatase MKP-1. Comparison of the binding activity of the JNK isoforms demonstrated that the JNK proteins differ in their interaction with ATF2, Elk-1 and Jun transcription factors. Individual members of the JNK group may therefore selectively target specific transcription factors in vivo.
-
Role of the Raf/mitogen-activated protein kinase pathway in p21ras desensitizationDesensitization of p21(ras) after stimulation of cells by growth factors and phorbol 12-myristate 13-acetate (PMA) correlates with hyperphosphorylation of the guanine nucleotide exchange factor Son-of-sevenless (Sos) and its dissociation from the adaptor protein Grb2 (Cherniack, A., Klarlund, J. K., Conway, B. R., and Czech, M. P. (1995) J. Biol. Chem. 270, 1485-1488). To test the role of the Raf/mitogen-activated protein (MAP) kinase pathway, we utilized cells expressing a chimera composed of the catalytic domain of p74Raf-1 and the hormone binding domain of the estradiol receptor (DeltaRaf-1:ER). Estradiol markedly stimulated DeltaRaf-1:ER and the downstream MEK and MAP kinases in these cells as well as Sos phosphorylation. However, the dissociation of Grb2 from Sos observed in response to PMA was not apparent upon DeltaRaf-1:ER activation. Furthermore, stimulation of DeltaRaf-1:ER did not impair GTP loading of p21(ras) in response to platelet-derived growth factor or epidermal growth factor. We conclude that activation of the Raf/MAP kinase pathway alone in these cells is insufficient to cause disassembly of Sos from Grb2 or to interrupt the ability of Sos to catalyze activation of p21(ras).
